Zdrowie i gospodarka · 14.06.2011
Draft Guidance for Industry; Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology; Availability
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology". This guidance is intended to provide industry with FDA's current thinking on whether FDA-regulated products contain nanomaterials or otherwise involve the application of nanotechnology. The points to consider are intended to be broadly applicable to all FDA-regulated products, with the understanding that additional guidance may be articulated for specific product areas, as appropriate in the future.